These questions are based off the Dataset Number 4 (Addictions) below....

Results

AA. Identify the null hypothesis and alternative hypothesis using appropriate statistical symbols and language based on what you are comparing.

A. Based on your results, determine whether the data provide evidence for a valid effect.

B. Explain whether or not the results are statistically significant. Support your response with results from the data analysis.

C. Present properly labeled graphs representing the data analysis results detailed clearly for ease of stakeholder interpretation.

. Conclusion

A. Explain your interpretation of the data. In other words, based on your results, what do you think the data mean? What are the potential implications of this data for the stakeholders? What do these results mean for future research into the topic area?

B. Justify the data analysis procedures you used to reach your interpretation.

C. Discuss whether it would be appropriate to conduct more statistical procedures to further interpret the data.

"The efficacy of a new addiction medication was evaluated in a randomized, placebo-controlled, doubleblind study. The medication in question, Antaquil, is intended to moderate the symptoms of alcohol withdrawal and craving with minimum side effects. Over the course of three weeks, a sample of 36 individuals who were recovering from alcohol addiction were randomly assigned to two groups: one administered the medication and one administered a placebo. At the end of the designated period, participants were administered the Obsessive Compulsive Drinking Scale (OCDS), an instrument that provides a global measure of thoughts about alcohol during nondrinking periods. Scores can range from 0 to 40 with higher scores signaling higher levels of rumination about alcohol. Prior to participation participants were all informed of the nature of Antaquil and were told they could leave the study at any time. Outcome data on the OCDS are shown below"

Treatment Gp 40 35 27 18 30 28 11 23 30 13 16 17 26 22 19 17 29 10

Placebo Gp 37 35 34 24 29 14 23 25 32 37 30 30 29 22 23 31 28 20